Sign in

CIK 0001395937 · Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320162505
Phone
781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
  1. 8-K Event Other events
  2. 8-K Event Material agreement
  3. 424B5 Offering Prospectus
  4. 424B5 Offering Prospectus
  5. 8-K Event Other events
  6. UPLOAD Other SEC-generated Letter
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. UPLOAD Other SEC-generated Letter
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. SC 13G Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 8-K Event Other events
  14. 4 Planned sale Director sold 52,855 shares at $18.27 ($965,402)
  15. 144 Insider Sale of Securities
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 4 Planned sale Director sold 83,000 shares at an average $20.46 ($1,697,810)
  19. 144 Insider Sale of Securities
  20. 8-K Event Other events

Page 9 of 33 · 660 filings